Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Inducible Urticaria”

54 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 54 results

Large-scale testing (Phase 3)Study completedNCT04681729
What this trial is testing

Dupilumab for the Treatment of Chronic Inducible Cold Urticaria in Patients Who Remain Symptomatic Despite the Use of H1-antihistamine (LIBERTY-CINDU CUrIADS)

Who this might be right for
Cold Urticaria
Sanofi 82
Testing effectiveness (Phase 2)WithdrawnNCT01211977
What this trial is testing

A Pilot Study of XOMA 052 in Familial Cold Autoinflammatory Syndrome / Muckle-Wells Syndrome and Behcet's Disease

Who this might be right for
Muckle Wells SyndromeAutoinflammatoryBehcet's Disease
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Testing effectiveness (Phase 2)Study completedNCT05812781
What this trial is testing

Evaluate VTX2735 in Patients With Cryopyrin-associated Periodic Syndrome

Who this might be right for
Cryopyrin Associated Periodic Syndrome
Zomagen Biosciences Ltd. 7
Testing effectiveness (Phase 2)Study completedNCT00859534
What this trial is testing

Phase II Solar Urticaria (SU) Pilot Study

Who this might be right for
Solar Urticaria
Clinuvel Pharmaceuticals Limited 5
Testing effectiveness (Phase 2)Looking for participantsNCT06865651
What this trial is testing

Study of Remibrutinib (LOU064) Efficacy and Safety and Exploration of Its Mechanism of Action in Participants With Chronic Urticaria

Who this might be right for
Chronic Urticaria (CU): Chronic Inducible Urticaria (CINDU) and Chronic Spontaneous Urticaria (CSU)
Novartis Pharmaceuticals 44
Early research (Phase 1)Study completedNCT00214851
What this trial is testing

The Use of Kineret (Anakinra) in the Treatment of Familial Cold Urticaria

Who this might be right for
Familial Cold Urticaria
Nova Scotia Health Authority 8
Not applicableStudy completedNCT04856540
What this trial is testing

Adult Outcomes of Children With CAPS

Who this might be right for
Cryopyrin Associated Periodic Syndrome
University Hospital, Lille 54
Testing effectiveness (Phase 2)Study completedNCT00487708
What this trial is testing

Safety, Efficacy, Pharmacokinetics, Pharmacodynamics of ACZ885 in Patients With NALP3 Mutations and Clinical Symptoms

Who this might be right for
NALP3 Mutation
Novartis Pharmaceuticals 34
Large-scale testing (Phase 3)Ended earlyNCT00770601
What this trial is testing

Canakinumab to Treat Neonatal-Onset Multisystem Inflammatory Disease

Who this might be right for
NOMIDCINCA Syndrome
Novartis Pharmaceuticals 7
Testing effectiveness (Phase 2)Ended earlyNCT04524858
What this trial is testing

Study of ATI-450 in Patients With Cryopyrin-Associated Periodic Syndrome (CAPS)

Who this might be right for
Cryopyrin-Associated Periodic Syndrome
Aclaris Therapeutics, Inc. 1
Testing effectiveness (Phase 2)Ended earlyNCT06353971
What this trial is testing

A Dose Escalation Trial of Safety, Pharmacokinetic/Pharmacodynamic and Preliminary Clinical Activity of Briquilimab in Adult Patients With Chronic Inducible Urticaria (CIndU) Who Remain Symptomatic Despite Treatment With H1- Antihistamines

Who this might be right for
Chronic Inducible Urticaria
Jasper Therapeutics, Inc. 27
Early research (Phase 1)Study completedNCT02175056
What this trial is testing

A Dose-Block Randomized, Placebo Controlled (Double-blind), Active Controlled(Open-label), Dose-escalation Study

Who this might be right for
Healthy Volunteers
Handok Inc. 58
Not applicableNot Yet RecruitingNCT05292768
What this trial is testing

Are Mast Cells Involved in Autoinflammatory Diseases

Who this might be right for
Autoinflammatory DiseaseFMFTRAPS+3 more
Assistance Publique - Hôpitaux de Paris 590
Testing effectiveness (Phase 2)Study completedNCT05405660
What this trial is testing

CDX-0159 in Patients With Chronic Inducible Urticaria

Who this might be right for
Chronic Inducible Urticaria
Celldex Therapeutics 196
Not applicableNot Yet RecruitingNCT06544018
What this trial is testing

Circadian Rhythm Deregulation in Patients With CAPS

Who this might be right for
Cryopyrin Associated Periodic SyndromeFamilial Cold UrticariaMuckle-Wells Syndrome+1 more
Hospices Civils de Lyon 30
Large-scale testing (Phase 3)Study completedNCT00991146
What this trial is testing

Efficacy and Safety Study of Canakinumab Administered for 6 Months (24 Weeks) in Japanese Patients With Cryopyrin-associated Periodic Syndromes Followed by an Extension Phase

Who this might be right for
Cryopyrin-associated Periodic SyndromesFamilial Cold Autoinflammatory SyndromeMuckle-Wells Syndrome+1 more
Novartis Pharmaceuticals 19
Early research (Phase 1)Study completedNCT06050928
What this trial is testing

Phase 1b, Open-Label Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of EP262 in Subjects With Chronic Inducible Urticaria

Who this might be right for
Chronic Inducible Urticaria
Escient Pharmaceuticals, Inc 33
Testing effectiveness (Phase 2)Study completedNCT06603220
What this trial is testing

A Study Evaluating the Safety, Tolerability, and Efficacy of EVO756 in Adults With Chronic Inducible Urticaria

Who this might be right for
Chronic Inducible Urticaria
Evommune, Inc. 30
Not applicableLooking for participantsNCT07359430
What this trial is testing

Deep Phenotyping of CIndU

Who this might be right for
Skin DiseasesAngio-Oedema and/or Urticaria
Centre for Human Drug Research, Netherlands 40
Testing effectiveness (Phase 2)Study completedNCT04868968
What this trial is testing

Study of Safety, Tolerability and Efficacy of DFV890 in Participants With Familial Cold Auto-inflammatory Syndrome (FCAS)

Who this might be right for
Familial Cold Autoinflammatory Syndrome
Novartis Pharmaceuticals 4
Load More Results